Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 01/01/2021 - 06/30/2021

Lobbyist name	Leslie Wood
Business name	Pharmaceutical Research and Manufacturers of America, Inc.
Address	950 F Street, NW Suite 300
City, state, zip code	Washington, DC 20004
Country	US
Agent type	Both
Phone	202-835-3451

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Pharmaceutical Research and Manufacturers of America, Inc.

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
Executive	Center for Health Information and Analysis (CHIA)	Discussed Center for Health Information and Analysis Annual Report, specifically related performance of the Massachusetts Health System	Neutral	$1,284.51	N/A
House Bill	1254	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Neutral	$240.84	N/A
Senate Bill	736	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Neutral	$240.85	N/A
Executive	Massachusetts Health Policy Commission (HPC)	Attended Health Policy Commission board meetings	Neutral	$1,605.64	N/A
			Total amount	$3,371.84

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.